BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1892678)

  • 1. Treatment of metastatic carcinoid tumors and the carcinoid syndrome with recombinant interferon alpha.
    Doberauer C; Mengelkoch B; Kloke O; Wandl U; Niederle N
    Acta Oncol; 1991; 30(5):603-5. PubMed ID: 1892678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of metastasized carcinoid tumor of the ileum and cecum with recombinant alpha-2b interferon].
    Doberauer C; Niederle N; Kloke O; Kurschel E; Schmidt CG
    Onkologie; 1987 Dec; 10(6):340-4. PubMed ID: 2450326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of metastatic carcinoid tumour with recombinant interferon alfa.
    Joensuu H; Kumpulainen E; Gröhn P
    Eur J Cancer; 1992; 28A(10):1650-3. PubMed ID: 1382493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic carcinoid tumors and the malignant carcinoid syndrome.
    Kvols LK
    Ann N Y Acad Sci; 1994 Sep; 733():464-70. PubMed ID: 7978896
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of malignant carcinoid tumors with recombinant interferon alfa-2b: development of neutralizing interferon antibodies and possible loss of antitumor activity.
    Oberg K; Alm G; Magnusson A; Lundqvist G; Theodorsson E; Wide L; Wilander E
    J Natl Cancer Inst; 1989 Apr; 81(7):531-5. PubMed ID: 2466128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferon.
    Moertel CG; Rubin J; Kvols LK
    J Clin Oncol; 1989 Jul; 7(7):865-8. PubMed ID: 2738623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of leukocyte interferon on clinical symptoms and hormone levels in patients with mid-gut carcinoid tumors and carcinoid syndrome.
    Oberg K; Funa K; Alm G
    N Engl J Med; 1983 Jul; 309(3):129-33. PubMed ID: 6191217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dose-escalation study of recombinant interferon-alpha in patients with a metastatic carcinoid tumour.
    Veenhof CH; de Wit R; Taal BG; Dirix LY; Wagstaff J; Hensen A; Huldij AC; Bakker PJ
    Eur J Cancer; 1992; 28(1):75-8. PubMed ID: 1373635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon-alpha-2a. A study by the Italian Trials in Medical Oncology Group.
    Bajetta E; Zilembo N; Di Bartolomeo M; Di Leo A; Pilotti S; Bochicchio AM; Castellani R; Buzzoni R; Celio L; Dogliotti L
    Cancer; 1993 Nov; 72(10):3099-105. PubMed ID: 7693327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant alpha-2b interferon in patients with malignant carcinoid tumour.
    Basser RL; Lieschke GJ; Sheridan WP; Fox RM; Green MD
    Aust N Z J Med; 1991 Dec; 21(6):875-8. PubMed ID: 1726359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of metastatic carcinoid with the somatostatin analog octreotide and with recombinant interferon alfa 2b].
    Linkesch M; Kuzmits R; Geyer G
    Wien Klin Wochenschr; 1989 Jun; 101(13):455-7. PubMed ID: 2763566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of malignant carcinoid tumors with human leukocyte interferon: long-term results.
    Oberg K; Norheim I; Lind E; Alm G; Lundqvist G; Wide L; Jonsdottir B; Magnusson A; Wilander E
    Cancer Treat Rep; 1986 Nov; 70(11):1297-304. PubMed ID: 2429764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.
    Smith DB; Scarffe JH; Wagstaff J; Johnston RJ
    Cancer Treat Rep; 1987 Dec; 71(12):1265-6. PubMed ID: 3690534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the treatment of metastatic carcinoid tumor with interferon not as successful as suggested?
    Välimäki M; Järvinen H; Salmela P; Sane T; Sjöblom SM; Pelkonen R
    Cancer; 1991 Feb; 67(3):547-9. PubMed ID: 1702352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers.
    Biesma B; Willemse PH; Mulder NH; Verschueren RC; Kema IP; de Bruijn HW; Postmus PE; Sleijfer DT; de Vries EG
    Br J Cancer; 1992 Nov; 66(5):850-5. PubMed ID: 1384643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of carcinoid syndrome with recombinant interferon alpha-2a.
    Di Bartolomeo M; Bajetta E; Zilembo N; de Braud F; Di Leo A; Verusio C; D'Aprile M; Scanni A; Barduagni M; Barduagni A [corrected to Barduagni M]
    Acta Oncol; 1993; 32(2):235-8. PubMed ID: 7686766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoid tumors and syndrome.
    Feldman JM
    Semin Oncol; 1987 Sep; 14(3):237-46. PubMed ID: 2442815
    [No Abstract]   [Full Text] [Related]  

  • 18. [2 year interferon therapy of metastatic carcinoid tumor].
    von Scheidt W; Böhm M; Huber I; Habersetzer R; Jacob K; Markl A; Autenrieth G
    Klin Wochenschr; 1990 Feb; 68(4):241-6. PubMed ID: 2107357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumours of the midgut (jejunum, ileum and ascending colon, including carcinoid syndrome).
    de Herder WW
    Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):705-15. PubMed ID: 16253895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of interferons in the management of carcinoid tumors.
    Oberg K; Eriksson B
    Acta Oncol; 1991; 30(4):519-22. PubMed ID: 1854509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.